Patient deaths, side effects resurface for Japanese HCV drug
TOKYO – A hepatitis C drug in the market in Japan since 2011 has been associated with 15 deaths in a little more than two years and with severe side effects in more than 2,500 patients, according to reports that surfaced over the weekend.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter